Cambridge CJC-1295 2mg/10vials is a high-quality peptide formulation designed for research and laboratory use. CJC-1295 is a synthetic analog of growth hormone–releasing hormone (GHRH) that is commonly studied for its potential to stimulate the natural release of growth hormone and IGF-1 in controlled research settings. Each package contains 10 vials, with 2 mg of CJC-1295 per vial, offering a reliable quantity for extended experimental applications.
This peptide is manufactured under strict quality standards to ensure purity, stability, and consistency between batches. Cambridge CJC-1295 2mg/10vials is typically supplied in lyophilized powder form, which helps maintain peptide integrity and allows researchers to reconstitute it easily for laboratory studies.
Researchers often select Cambridge CJC-1295 2mg/10vials for its precise dosing, convenient multi-vial packaging, and dependable peptide quality. The product is intended strictly for scientific and research purposes, making it a suitable option for laboratories investigating peptide behavior, hormone signaling pathways, and related biochemical processes.